Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF

Background: Rivaroxaban, a direct oral anticoagulant (DOAC), has become available for stroke prevention in patients with non-valular atrial fibrillation (NVAF). However, little is known about its effectiveness and safety when prescribed by general practitioners in real-life settings. Methods: GENERA...

Full description

Bibliographic Details
Main Authors: Kengo Kusano, MD, PhD, Masaharu Akao, MD, PhD, Hikari Tsuji, MD, Kunihiko Matsui, MD, MPH, Shinya Hiramitsu, MD, Yutaka Hatori, MD, Hironori Odakura, MD
Format: Article
Language:English
Published: Wiley 2017-08-01
Series:Journal of Arrhythmia
Subjects:
Anticoagulants
DOAC
Non-valvular atrial fibrillation
Stroke
General practitioner
Online Access:http://www.sciencedirect.com/science/article/pii/S1880427616307311

Internet

http://www.sciencedirect.com/science/article/pii/S1880427616307311

Similar Items